C-Myc-mediated Repression of MiR-15-16 in Hypoxia is Induced by Increased HIF-2α and Promotes Tumor Angiogenesis and Metastasis by Upregulating FGF2

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2014 Apr 8

PMID 24704828

Citations 49

Authors

G Xue

H-L Yan

Y Zhang

L-Q Hao

X-T Zhu

Q Mei

S-H Sun

Affiliations

Soon will be listed here.

Abstract

Previous studies have established the link between aberrant microRNA (miRNA) expression and hypoxia in various neoplasms. However, how these hypoxia-related miRNAs modulate tumor progression is still unclear. Therefore, the patterns of miRNA in colorectal carcinoma cell lines in response to hypoxia or not were first screened and the hypoxia-induced repression of the miR-15-16 cluster was confirmed. Then, this repression was found to be associated with high tumor stage and poor prognosis in colorectal carcinoma and is shown to promote tumor angiogenesis and metastasis by the loss of restriction of its target gene, fibroblast growth factor-2 (FGF2). Moreover, the general and alterative promoters of the miR-15-16 host (deleted in lymphocytic leukemia 2, DLEU2) were mapped, and three c-Myc/Max binding sites in response to the hypoxia-induced repression of miR-15-16 were further identified. Finally, an enhanced stability of c-Myc/Max heterodimer promoted by increased hypoxia-inducible factor-2α (HIF-2α) was validated, and we also verified that the enhancement contributed to the hypoxia-induced repression of miR-15-16. In brief, the c-Myc-mediated transcriptional repression of miR-15-16 in hypoxia is induced by increased HIF-2α and promoted tumor angiogenesis and hematogenous metastasis by the further loss of post-transcriptional inhibition of FGF2. Our study provides a better understanding of the coping mechanisms in response to tumor hypoxia and may be helpful in developing an effective prognostic marker or treatment target against solid tumors.

Citing Articles

c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a.

Dong C, Sun Y, Xu X, Li H, Song X, Wei W Breast Cancer. 2025; .

PMID: 40029493 DOI: 10.1007/s12282-025-01683-w.

Molecular Genetics of Pheochromocytoma/Paraganglioma.

Wachtel H, Nathanson K Curr Opin Endocr Metab Res. 2024; 36.

PMID: 39328362 PMC: 11424047. DOI: 10.1016/j.coemr.2024.100527.

miR-107 Targets NSG1 to Regulate Hypopharyngeal Squamous Cell Carcinoma Progression through ERK Pathway.

Hu Y, He Z, Han B, Lin Z, Zhou P, Li S Int J Mol Sci. 2024; 25(11).

PMID: 38892156 PMC: 11172869. DOI: 10.3390/ijms25115961.

The roles of long non-coding RNAs in ovarian cancer: from functions to therapeutic implications.

Hu Z, Yuan L, Yang X, Yi C, Lu J Front Oncol. 2024; 14:1332528.

PMID: 38725621 PMC: 11079149. DOI: 10.3389/fonc.2024.1332528.

Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further Enhance Anticancer Drug Development.

Kimura K, Jackson T, Huang R Curr Issues Mol Biol. 2023; 45(11):9262-9283.

PMID: 37998757 PMC: 10670631. DOI: 10.3390/cimb45110580.

References

Vaupel P, Mayer A . Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007; 26(2):225-39. DOI: 10.1007/s10555-007-9055-1. View

Chan D, Giaccia A . Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev. 2007; 26(2):333-9. DOI: 10.1007/s10555-007-9063-1. View

Buendia M, Bourre L, Cairo S . Myc target miRs and liver cancer: small molecules to get Myc sick. Gastroenterology. 2011; 142(2):214-8. DOI: 10.1053/j.gastro.2011.12.023. View

Horan A, Koch C . The K(m) for Radiosensitization of Human Tumor Cells by Oxygen is Much Greater than 3 mmHg and is Further Increased by Elevated Levels of Cysteine. Radiat Res. 2001; 156(4):388-98. DOI: 10.1667/0033-7587(2001)156[0388:tkmfro]2.0.co;2. View

Voss M, Niggemann B, Zanker K, Entschladen F . Tumour reactions to hypoxia. Curr Mol Med. 2010; 10(4):381-6. DOI: 10.2174/156652410791317020. View

Cao Y, Arbiser J, DAmato R, DAmore P, Ingber D, Kerbel R . Forty-year journey of angiogenesis translational research. Sci Transl Med. 2011; 3(114):114rv3. PMC: 8265598. DOI: 10.1126/scitranslmed.3003149. View

Lerner M, Harada M, Loven J, Castro J, Davis Z, Oscier D . DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res. 2009; 315(17):2941-52. DOI: 10.1016/j.yexcr.2009.07.001. View

Hackl C, Man S, Francia G, Milsom C, Xu P, Kerbel R . Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models. Gut. 2012; 62(2):259-71. PMC: 3553490. DOI: 10.1136/gutjnl-2011-301585. View

Segura M, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S . Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A. 2009; 106(6):1814-9. PMC: 2634798. DOI: 10.1073/pnas.0808263106. View

10.

Ruan K, Song G, Ouyang G . Role of hypoxia in the hallmarks of human cancer. J Cell Biochem. 2009; 107(6):1053-62. DOI: 10.1002/jcb.22214. View

11.

Aqeilan R, Calin G, Croce C . miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 2009; 17(2):215-20. DOI: 10.1038/cdd.2009.69. View

12.

Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L . The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 2008; 14(11):1271-7. DOI: 10.1038/nm.1880. View

13.

Croce C . Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009; 10(10):704-14. PMC: 3467096. DOI: 10.1038/nrg2634. View

14.

Winter J, Jung S, Keller S, Gregory R, Diederichs S . Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009; 11(3):228-34. DOI: 10.1038/ncb0309-228. View

15.

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

16.

Bristow R, Hill R . Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer. 2008; 8(3):180-92. DOI: 10.1038/nrc2344. View

17.

Gupta G, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K . ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A. 2007; 104(49):19506-11. PMC: 2148319. DOI: 10.1073/pnas.0709185104. View

18.

Le Q, Denko N, Giaccia A . Hypoxic gene expression and metastasis. Cancer Metastasis Rev. 2004; 23(3-4):293-310. DOI: 10.1023/B:CANC.0000031768.89246.d7. View

19.

Khew-Goodall Y, Goodall G . Myc-modulated miR-9 makes more metastases. Nat Cell Biol. 2010; 12(3):209-11. DOI: 10.1038/ncb0310-209. View

20.

Stockmann C, Doedens A, Weidemann A, Zhang N, Takeda N, Greenberg J . Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature. 2008; 456(7223):814-8. PMC: 3103772. DOI: 10.1038/nature07445. View